Advertisement

Topics

Celladon Corporation Company Profile

17:04 EST 20th January 2017 | BioPortfolio

Celladon Corporation, based in La Jolla, California, was launched in October 2004 as a privately held biotechnology company founded with the goal of becoming the leader in developing molecular therapies for the treatment of heart failure. The company’s products target the key enzyme deficiency in advanced heart failure, SERCA2a, which regulates calcium cycling and contractility in heart muscle cells. Celladon’s first product candidate, MYDICAR®, delivers the gene for the SERCA2a enzyme and is currently being tested in Phase 1 and 2 clinical trials. Celladon is also developing traditional small molecule activators of SERCA2a for the treatment of heart failure. To learn more about Celladon, visit Celladon’s website at www.celladon.net.

Location

2223 Avenida de la Playa #206
La Jolla
California
92037
United States of America

Contact

Phone: 858.366.4288
Fax: 858.964.0974
Email: info@celladon.net


News Articles [127 Associated News Articles listed on BioPortfolio]

Vivione Biosciences Inc. Announces Closing of Shares for Debt Transaction

CALGARY, ALBERTA -- (Marketwired) -- 08/08/16 -- Vivione Biosciences Inc. ("Vivione" or the "Corporation") (NEX: VBI.H) is pleased to announce that it has completed the previously announced shares f...

Oriola-KD Corporation's 50,375 A-shares converted into B-shares

Oriola-KD Corporation Stock Exchange Release 4 January 2017 at 9.00 a.m. Oriola-KD Corporation's 50,375 A-shares converted into B-shares In accordance with Section 3 of the Byla...

Oriola-KD Corporation will publish the interim report 1 January - 30 September 2016 on Thursday, 20 October 2016 at 8.30 a.m.

Oriola-KD Corporation Stock Exchange Release 7 October 2016 at 2.00 p.m. Oriola-KD Corporation will publish the interim report 1 January - 30 September 2016 on Thursday, 20 October 201...

Publication schedule for Oriola-KD Corporation's financial reporting in 2017

Oriola-KD Corporation Stock Exchange Release 24 November 2016 at 1.00 p.m. Publication schedule for Oriola-KD Corporation's financial reporting in 2017 Oriola-KD Corporation will...

Eiger nets $18.8mm via FOPO

In its first financing since reverse merging with Celladon, Eiger BioPharmaceuticals Inc. (rare diseases) netted $18.8mm through the follow-on public offering of 1.25mm common shares at $16 each. The ...

National Research Corporation Declares Quarterly Dividend

LINCOLN, NE--(Marketwired - August 30, 2016) - National Research Corporation (NASDAQ: NRCIA) (NASDAQ: NRCIB) today announced that its Board of Directors has declared a quarterly cash dividend of $0.0...

CORRECTION: Oriola-KD Corporation will publish the interim report 1 January - 30 September 2016 on Thursday, 20 October 2016 at 8.30 a.m.

This is a correction of the announcement from 14:00 07.10.2016 EEST. Reason for the correction: There was an error considering the meeting schedule for investors, analysts and the pre...

Oriola-KD Corporation: Notification of managers' transactions

Oriola-KD Corporation Stock Exchange Release 4 November 2016 at 12.00 Oriola-KD Corporation: Notification of managers' transactions ...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [3 Associated Companies listed on BioPortfolio]

Celladon Corp.

Celladon Corp., based in La Jolla, Calif., was launched in October 2004 as a privately held biotechnology company with the goal of becoming the leader in developing molecular therapies for the treatme...

Celladon Corporation

Celladon Corporation, based in La Jolla, California, was launched in October 2004 as a privately held biotechnology company founded with the goal of becoming the leader in develop...

Quorum Health Corporation

Quorum Health Corporation will be an operator and manager of general acute care hospitals and outpatient services in the United States. QHC will own or lease a diversified portfol...

More Information about "Celladon Corporation" on BioPortfolio

We have published hundreds of Celladon Corporation news stories on BioPortfolio along with dozens of Celladon Corporation Clinical Trials and PubMed Articles about Celladon Corporation for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Celladon Corporation Companies in our database. You can also find out about relevant Celladon Corporation Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Enzymes
Enzymes are proteins that catalyze (i.e., increase the rates of) chemical reactions. In enzymatic reactions, the molecules at the beginning of the process, called substrates, are converted into different molecules, called products. Almost all chemical re...


Corporate Database Quicklinks



Searches Linking to this Company Record